Synthesis and In Vitro Evaluation of Caffeoylquinic Acid Derivatives as Potential Hypolipidemic Agents

Molecules. 2019 Mar 9;24(5):964. doi: 10.3390/molecules24050964.

Abstract

A series of novel caffeoylquinic acid derivatives of chlorogenic acid have been designed and synthesized. Biological evaluation indicated that several synthesized derivatives exhibited moderate to good lipid-lowering effects on oleic acid-elicited lipid accumulation in HepG2 liver cells. Particularly, derivatives 3d, 3g, 4c and 4d exhibited more potential lipid-lowering effect than the positive control simvastatin and chlorogenic acid. Further studies on the mechanism of 3d, 3g, 4c and 4d revealed that the lipid-lowering effects were related to their regulation of TG levels and merit further investigation.

Keywords: HepG2 cells; caffeoylquinic acids; chlorogenic acid; derivatives; lipid-lowering effects; oleic acid-elicited.

MeSH terms

  • Chlorogenic Acid / pharmacology
  • Hep G2 Cells
  • Humans
  • Hypolipidemic Agents / chemical synthesis*
  • Hypolipidemic Agents / chemistry
  • Hypolipidemic Agents / pharmacology*
  • Lipid Metabolism / drug effects
  • Oleic Acid / pharmacology*
  • Quinic Acid / analogs & derivatives*
  • Quinic Acid / chemical synthesis
  • Quinic Acid / chemistry
  • Quinic Acid / pharmacology
  • Simvastatin / pharmacology

Substances

  • Hypolipidemic Agents
  • caffeoylquinic acid
  • Quinic Acid
  • Oleic Acid
  • Chlorogenic Acid
  • Simvastatin